Home

Badreddin Edris

CIK 1786966 · Chief Operating Officer · last filed 2026-06-16

Badreddin Edris is a Chief Operating Officer who has filed 28 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for EWTX, was dated Jun 16, 2026. Across all open-market trades the lifetime net is −$14.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.66M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$13.95M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EWTX Director 61,209 $43.52 $2.66M -$3.40M 6 2026-06-16
SpringWorks Therapeutics, Inc. (SWTX) Delisted Chief Operating Officer 0 $46.99 $0 -$10.55M 18 2025-07-02

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-16 EWTX Grant (A) — $0 EDGAR
2026-01-23 EWTX Mixed — -$3.23M EDGAR
2026-01-21 EWTX Notice (144) −115,471 -$3.35M EDGAR
2025-07-02 SpringWorks Therapeutics, Inc. (SWTX) Delisted Disp (D) −169,712 $0 EDGAR
2025-06-18 EWTX Grant (A) — $0 EDGAR
2025-03-05 SpringWorks Therapeutics, Inc. (SWTX) Delisted Sell (S) −20,000 -$1.08M EDGAR
2025-02-12 SpringWorks Therapeutics, Inc. (SWTX) Delisted Sell (S) −30,000 -$1.59M EDGAR
2025-02-10 SpringWorks Therapeutics, Inc. (SWTX) Delisted Notice (144) −50,000 -$2.05M EDGAR
2025-01-14 SpringWorks Therapeutics, Inc. (SWTX) Delisted Grant (A) +27,023 $0 EDGAR
2025-01-07 SpringWorks Therapeutics, Inc. (SWTX) Delisted Tax (F) −16,911 -$648.8K EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.